129 related articles for article (PubMed ID: 37499848)
21. Zizhines G-O, AchE inhibitory meroterpenoids from Ganoderma sinensis.
Luo Q; Cao WW; Wu ZH; Wang SM; Cheng YX
Fitoterapia; 2019 Apr; 134():411-416. PubMed ID: 30902752
[TBL] [Abstract][Full Text] [Related]
22. Meroterpenoids containing benzopyran or benzofuran motif from Ganoderma cochlear.
Qin FY; Wang DW; Xu T; Zhang BS; Cheng YX
Phytochemistry; 2022 Jul; 199():113184. PubMed ID: 35405148
[TBL] [Abstract][Full Text] [Related]
23. Australeols A-F, neuroprotective meroterpenoids from Ganoderma australe.
Zhang JJ; Dong Y; Qin FY; Cheng YX
Fitoterapia; 2019 Apr; 134():250-255. PubMed ID: 30825574
[TBL] [Abstract][Full Text] [Related]
24. Lanostane triterpenoids with anti-inflammatory activities from Ganoderma lucidum.
Su HG; Peng XR; Shi QQ; Huang YJ; Zhou L; Qiu MH
Phytochemistry; 2020 May; 173():112256. PubMed ID: 32062196
[TBL] [Abstract][Full Text] [Related]
25. Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe.
Guo JC; Yang L; Ma QY; Ge YZ; Kong FD; Zhou LM; Fei Zhang ; Xie QY; Yu ZF; Dai HF; Zhao YX
Bioorg Chem; 2021 Dec; 117():105448. PubMed ID: 34736135
[TBL] [Abstract][Full Text] [Related]
26. Isolation and Characterization of trans-p-Hydroxycinnamoyl Meroterpenoids from Ganoderma sinensis.
Yin YJ; Zhou H; Zhang JJ; Cai D; Yuan YN; Yang ZH; Cheng YX
Chem Biodivers; 2023 Apr; 20(4):e202300022. PubMed ID: 36971262
[TBL] [Abstract][Full Text] [Related]
27. Lucidumones B-H, racemic meroterpenoids that inhibit tumor cell migration from Ganoderma lucidum.
Cai D; Zhang JJ; Wu ZH; Qin FY; Yan YM; Zhang M; Cheng YX
Bioorg Chem; 2021 May; 110():104774. PubMed ID: 33711656
[TBL] [Abstract][Full Text] [Related]
28. (±) Gancochlearols A and B: cytotoxic and COX-2 inhibitory meroterpenoids from
Qin FY; Yan YM; Tu ZC; Cheng YX
Nat Prod Res; 2020 Aug; 34(16):2269-2275. PubMed ID: 30518262
[TBL] [Abstract][Full Text] [Related]
29. (±) Cochlearoids N-P: three pairs of phenolic meroterpenoids from the fungus Ganoderma cochlear and their bioactivities.
Qin FY; Yan YM; Tu ZC; Cheng YX
J Asian Nat Prod Res; 2019 Jun; 21(6):542-550. PubMed ID: 29985069
[TBL] [Abstract][Full Text] [Related]
30. Meroterpenoids and alkaloids from
Zhang JJ; Dong Y; Qin FY; Yan YM; Cheng YX
Nat Prod Res; 2021 Oct; 35(19):3226-3232. PubMed ID: 31741407
[TBL] [Abstract][Full Text] [Related]
31. Distinguishing commercially grown Ganoderma lucidum from Ganoderma lingzhi from Europe and East Asia on the basis of morphology, molecular phylogeny, and triterpenic acid profiles.
Hennicke F; Cheikh-Ali Z; Liebisch T; Maciá-Vicente JG; Bode HB; Piepenbring M
Phytochemistry; 2016 Jul; 127():29-37. PubMed ID: 27044336
[TBL] [Abstract][Full Text] [Related]
32. Spiro Meroterpenoids from Ganoderma applanatum.
Luo Q; Wei XY; Yang J; Luo JF; Liang R; Tu ZC; Cheng YX
J Nat Prod; 2017 Jan; 80(1):61-70. PubMed ID: 27996259
[TBL] [Abstract][Full Text] [Related]
33. Diverse meroterpenoids with α-glucosidase inhibitory activity from Ganoderma cochlear.
Fang DS; Cheng CR; Qiu MH; Peng XR
Fitoterapia; 2023 Mar; 165():105420. PubMed ID: 36586625
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of quorum sensing in the opportunistic pathogenic bacterium Chromobacterium violaceum by an extract from fruiting bodies of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W.Curt.:Fr.) P. Karst. (higher Basidiomycetes).
Zhu H; Liu W; Tian B; Liu H; Ning S
Int J Med Mushrooms; 2011; 13(6):559-64. PubMed ID: 22181844
[TBL] [Abstract][Full Text] [Related]
35. Two new compounds from Ganoderma lucidum.
Wang XF; Yan YM; Wang XL; Ma XJ; Fu XY; Cheng YX
J Asian Nat Prod Res; 2015; 17(4):329-32. PubMed ID: 25295637
[TBL] [Abstract][Full Text] [Related]
36. Alkaloids, sesquiterpenoids and hybrids of terpenoid with p-hydroxycinnamic acid from Ganoderma sinensis and their biological evaluation.
Luo Q; Cao WW; Cheng YX
Phytochemistry; 2022 Nov; 203():113379. PubMed ID: 36029844
[TBL] [Abstract][Full Text] [Related]
37. Racemic meroterpenoids from Ganoderma cochlear.
Peng X; Wang X; Chen L; Yang H; Li L; Lu S; Zhou L; Qiu M
Fitoterapia; 2018 Jun; 127():286-292. PubMed ID: 29540310
[TBL] [Abstract][Full Text] [Related]
38. COX-2 and iNOS inhibitory epimeric meroterpenoids from Ganoderma cochlear and structure revision of cochlearol Q.
Sura MB; Peng YL; Cai D; Cheng YX
Fitoterapia; 2023 Jan; 164():105390. PubMed ID: 36513292
[TBL] [Abstract][Full Text] [Related]
39. Meroterpenoid dimers from Ganoderma cochlear and their cytotoxic and COX-2 inhibitory activities.
Qin FY; Yan YM; Tu ZC; Cheng YX
Fitoterapia; 2018 Sep; 129():167-172. PubMed ID: 29969649
[TBL] [Abstract][Full Text] [Related]
40. Lanostane-type triterpenoids from the fruiting bodies of Ganoderma applanatum.
Peng X; Li L; Dong J; Lu S; Lu J; Li X; Zhou L; Qiu M
Phytochemistry; 2019 Jan; 157():103-110. PubMed ID: 30390604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
